CClinicalTrials.gg
CompletedNCT06878040Updated Mar 20, 2025

Effect of Baseline Ferritin Level on Iron Status in Male Elite Youth Rowers

An observational study in Inflammation, Iron Deficiency Anemias and Red Blood Cell, sponsored by Poznan University of Physical Education. Completed at 1 site in Poland. Open to male participants aged 18 Years to 24 Years. Per ClinicalTrials.gov, last updated 2025-03-20.

Sponsored by Poznan University of Physical Education · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
16
Ages
18 Years to 24 Years
Sex
Male
01

Study summary

The data of 16 trained men from the Polish Youth National Rowing. All athletes presented as medically fit, with no underlying health problems. In this cohort, baseline serum ferritin levels were considered, and the athletes were divided into two groups:

  1. Serum ferritin \<75 ng/ml (SF\<75): n=9
  2. Serum ferritin >75 ng/ml (SF>75): n=7

The rowing test was performed at the beginning of the preparatory phase of the annual training cycle (April), which is characterized by high volume and training load. After a 5-min of individual warm-up, the athletes performed a 2000-m exercise test on a rowing ergometer (Concept II, USA). Blood samples took from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 1-hour recovery period (1h recovery).

Measurements ferritin, transferrin, hepcidin and interleukin-6 (IL-6) levels were determined using ELISA kits (SunRed Biotechnology Company). The iron levels were determined on the SPECTROstar Nano reader.

Read the detailed description

The data of 16 trained men from the Polish Youth National Rowing. All athletes presented as medically fit, with no underlying health problems. In this cohort, baseline serum ferritin levels were considered, and the athletes were divided into two groups:

  1. Serum ferritin \<75 ng/ml (SF\<75): n=9
  2. Serum ferritin >75 ng/ml (SF>75): n=7

The rowing test was performed at the beginning of the preparatory phase of the annual training cycle (April), which is characterized by high volume and training load. After a 5-min of individual warm-up, the athletes performed a 2000-m exercise test on a rowing ergometer (Concept II, USA). Blood samples took from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 1-hour recovery period (1h recovery).

Measurement: All determined parameters will be measured with the available equipment in the ZWKF laboratory in Gorzów Wielkopolski and using commercial assay kits. Measurements will be performed by the project contractors.

  1. Polyethylene tubes (2.7ml) containing dipotassium ethylenediaminetetraacetic acid (EDTAK2) anticoagulant will be used for the following tests:

    (a) complete blood count (7 parameters) determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland). Red blood cell indices: RBC (Red Blood Cells), HGB (Hemoglobin), HCT (Hematocrit), MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Hemoglobin), MCHC (Mean Corpuscular Hemoglobin Concentration), RDW (Red Blood cells Distribution Width).

  2. Polyethylene clotting activator tubes (9 ml) will be centrifuged to separate the morphotic elements from the serum using a centrifuge (3000 rpm for 10 min). The serum will be pipetted into several Eppendorf tubes, which will then be frozen (temp. -80 °C). All the following biochemical parameters will be determined from the extracted serum:

    1. using the ELISA method by the test manufacturer's instructions. The designations include the flowing parameters:

      • iron status parameters: hepcidin, transferrin , ferritin,
      • indicators of inflammation: IL-6.
    2. The iron levels be determined using the colorimetric method on the SPECTROstar Nano reader.
  3. The lactate (La) concentration will be determined from the capillary blood immediately after collection using a commercially available kit (Dr. Lange, Germany).

Youth National Rowing Team of Poland The athletes' diets were completely analyzed before each exercise test by a nutritionist. Participants, with the help of a dietician who was available during meals on test days, filled out food diaries. The amount of energy, protein, carbohydrates, fats and fiber were then analyzed using a commercially available program.

The experiment was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethical Committee of the Medical University of Poznan (decision no. 685/23 in 2023).

02

Conditions studied

  • Inflammation
  • Iron Deficiency Anemias
  • Red Blood Cell
03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's enrollment of 16 is below the median of 200 across 113 observational studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Poznan University of Physical Education is the lead sponsor of 90 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Youth National Rowing Team of Poland

Inclusion criteria

  • Training experience a minimum of five years
  • Minimum training time per week 240 minute
  • Membership in the Youth National Rowing Team of Poland
  • Completion of the 2000m ergometer test on two test dates

Exclusion criteria

Exclusion Criteria:

  • Taking other supplements containing anthocyanin compounds during the study period or a month earlier
  • Antibiotic therapy
  • Health problems
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
16 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Ferritin

    Concentration of ferritin \[ng/mL\]. ELISA method by the test manufacturer's instructions

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  2. Iron

    The iron level \[µg/dL\] will be determined using the colorimetric method on the SPECTROstar Nano reader.

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  3. Interleukin-6 (Il-6)

    Concentration of IL-6 \[ng/L\]. ELISA method by the test manufacturer's instructions

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  4. Hepcidin

    Concentration of hepcidin \[ng/mL\]. ELISA method by the test manufacturer's instructions

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  5. Transferrin

    Concentration of transferrin \[mg/mL\]. ELISA method by the test manufacturer's instructions

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  6. The Blood morphology - RBC (Red Blood Cells)

    RBC (Red Blood Cells) \[106 × µL-1\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  7. The Blood morphology- HGB (Hemoglobin)

    HGB (Hemoglobin) \[g/dL\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  8. The Blood morphology- HCT (Hematocrit)

    HCT (Hematocrit) \[%\]determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  9. The Blood morphology- MCV (Mean Corpuscular Volume)

    MCV (Mean Corpuscular Volume)\[fl\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  10. The Blood morphology- MCH (Mean Corpuscular Hemoglobin)

    MCH (Mean Corpuscular Hemoglobin) \[pg\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  11. The Blood morphology- MCHC (Mean Corpuscular Hemoglobin Concentration)

    MCHC (Mean Corpuscular Hemoglobin Concentration) \[g x dL-1\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

  12. The Blood morphology- RDW (Red Blood cells Distribution Width)

    RDW (Red Blood cells Distribution Width) \[%\] determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland).

    Time frame: At rest (before the test), directly after the test, and after a 1-hour recovery period.

Secondary outcomes

  1. Antropometric characteristic - height

    Prior to the exercise test, the investigators measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) \[cm\]

    Time frame: Day 1 after overall fast

  2. Antropometric characteristic - weight

    Prior to the exercise test, the investigators measured the anthropometric parameters, including weight (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) \[kg\]

    Time frame: Day 1 after overall fast

  3. Food record - energy

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: energy \[kcal\]

    Time frame: Day before the Day 1, in the morning at Day 1

  4. Food record - protein

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: protein \[g\]

    Time frame: Day before the Day 1, in the morning at Day 1

  5. Food record - carobhydrates

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: carbohydrates \[g\]

    Time frame: Day before the Day 1, in the morning at Day 1

  6. Food record - fiber

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: fiber \[g\]

    Time frame: Day before the Day 1, in the morning at Day 1

  7. Food record - fat

    Participants will prepare a food record. The results will be calculated using the dietetykpro program: fat \[g\]

    Time frame: Day before the Day 1, in the morning at Day 1

07

Study locations

1 site
  • Poznań University of Physical Education,
    Poznań, 61-871, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06878040
Lead sponsor
Poznan University of Physical Education
Responsible party
Sponsor
First posted
Mar 14, 2025
Start date
Apr 1, 2023
Primary completion
Jun 10, 2023
Completion
Jun 10, 2023
Last update
Mar 20, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion